Invasive aspergillosis with pulmonary and central nervous system involvement during ibrutinib therapy for relapsed chronic lymphocytic leukaemia: case report

Clin Microbiol Infect. 2018 Jul;24(7):785-786. doi: 10.1016/j.cmi.2018.01.028. Epub 2018 Feb 7.

Authors

A M Peri¹, L Bisi², A Cappelletti², E Colella², L Verga³, C Borella³, S Foresti², G M Migliorino², A Gori², A Bandera²

Affiliations

¹ Division of Infectious Diseases, San Gerardo Hospital, ASST Monza (MB), Italy. Electronic address: annamaria.peri@asst-monza.it.
² Division of Infectious Diseases, San Gerardo Hospital, ASST Monza (MB), Italy.
³ Hematology Department, San Gerardo Hospital, ASST Monza (MB), Italy.

PMID: 29427802
DOI: 10.1016/j.cmi.2018.01.028

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives
Antifungal Agents / pharmacology
Antifungal Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy
Blood Culture / methods
Central Nervous System Fungal Infections / diagnosis*
Central Nervous System Fungal Infections / drug therapy
Central Nervous System Fungal Infections / etiology*
Humans
Invasive Pulmonary Aspergillosis / diagnosis*
Invasive Pulmonary Aspergillosis / drug therapy
Invasive Pulmonary Aspergillosis / etiology*
Leukemia, Lymphocytic, Chronic, B-Cell / complications*
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Neoplasm Recurrence, Local
Piperidines
Pyrazoles / administration & dosage
Pyrazoles / adverse effects*
Pyrazoles / therapeutic use
Pyrimidines / administration & dosage
Pyrimidines / adverse effects*
Pyrimidines / therapeutic use
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antifungal Agents
Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine